Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Cytosorbents Logo
Cytosorbents Growth Score
25
CB Rank
85574
Heat Score
55
Cytosorbents develops therapeutic devices used in purifying blood to treat life-threatening diseases.
Founded
obfuscation
PublicPost-IPO Equity Monmouth Junction, New Jersey, United States101-250 cytosorbents.com
Biotechnology
Pharmaceutical
Therapeutics
Overview

Cytosorbents
Total Funding
obfuscation
Growth Score
25
Heat Score
55

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score25
-9 pts
in past quarter
Heat Score 55
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Cytosorbents

CB Rank
85574
Cytosorbents develops therapeutic devices used in purifying blood to treat life-threatening diseases.
Founded
obfuscation
PublicPost-IPO Equity Monmouth Junction, New Jersey, United States101-250 cytosorbents.com
Biotechnology
Pharmaceutical
Therapeutics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Medasorb Technologies Corporation
Operating Status Active
Stock Symbol  NASDAQ:CTSO
Company Type For Profit
Founders  Frank Clark
About the Company

CytoSorbents Corporation is a publicly-traded, critical care focused therapeutic device company using blood purification to treat life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface

adsorption. Each polymer bead contains millions of pores and channels that can be modified to remove substances as small as drugs, to substances as large as antibodies.

Phone Number 7323298650
Contact Email info@cytosorbents.com
Predictions & Insights

Growth Insight

See this Growth Insight
Cytosorbents is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Products & Services

CytoSorb
An extracorporeal blood purification device that removes excessive harmful substances like cytokines, bilirubin, and myoglobin to restore balance and support organ function in critical care and cardiovascular patients.
DrugSorb-ATR
An investigational device designed to remove antithrombotic drugs such as ticagrelor and rivaroxaban during cardiothoracic surgery to reduce perioperative bleeding risks.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 12
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Cytosorbents Logo
Post-IPO Equity - Cytosorbents
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Cytosorbents Logo
Post-IPO Equity - Cytosorbents
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Cytosorbents Logo
Post-IPO Equity - Cytosorbents
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Cytosorbents Logo
Post-IPO Equity - Cytosorbents
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Cytosorbents Logo
Post-IPO Equity - Cytosorbents
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 12
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Cytosorbents Logo
Post-IPO Equity - Cytosorbents
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Cytosorbents Logo
Post-IPO Equity - Cytosorbents
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Cytosorbents Logo
Post-IPO Equity - Cytosorbents
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Cytosorbents Logo
Post-IPO Equity - Cytosorbents
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Cytosorbents Logo
Post-IPO Equity - Cytosorbents
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Avenue Capital Group Logo
Avenue Capital Group
Yes
Post-IPO Debt - Cytosorbents Logo
Post-IPO Debt - Cytosorbents
—
Avenue Capital Group Logo
Avenue Capital Group
Yes
Post-IPO Debt - Cytosorbents Logo
Post-IPO Debt - Cytosorbents
—
Avenue Capital Group Logo
Avenue Capital Group
Yes
Post-IPO Debt - Cytosorbents Logo
Post-IPO Debt - Cytosorbents
—
Avenue Capital Group Logo
Avenue Capital Group
Yes
Post-IPO Debt - Cytosorbents Logo
Post-IPO Debt - Cytosorbents
—
Avenue Capital Group Logo
Avenue Capital Group
Yes
Post-IPO Debt - Cytosorbents Logo
Post-IPO Debt - Cytosorbents
—
Market Intelligence
People
View Profiles & Contacts
Headcount 101-250 Employee Profiles 11 Board Members and Advisors 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 14, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 13, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 30, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 26, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

3,509
217.27%
 in past month

IT Spend

$1.2MThis year, Cytosorbents is projected to spend $1.2M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Firewire Logo
Firewire
100
Equinix Connect Logo
Equinix Connect
100
Rocketfuel (FUEL) Logo
Rocketfuel (FUEL)
98

Actively Used Products

17Cytosorbents uses 17 technology products and services including HTML5, Bootstrap, and  Google Fonts, according to G2 Stack.

Active Website Tech Count

47Cytosorbents is actively using 47 technologies for its website, according to BuiltWith. These include HSTS, Apple Mobile Web Clips Icon, and  Euro.

Total IP

1Cytosorbents has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Cytosorbents's headquarters? Cytosorbents is located in Monmouth Junction, New Jersey, United States.Who invested in Cytosorbents? Cytosorbents has 4 investors including Avenue Capital Group and  Bridge Bank.When was the last funding round for Cytosorbents? Cytosorbents closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Cytosorbents's competitors? Alternatives and possible competitors to Cytosorbents may include Inspira Technologies, Mozarc Medical, and  SeaStar Medical.How much funding has Cytosorbents raised to date? Cytosorbents has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|